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HISTORY OF SCIENCE 
CONTRIBUTIONS OF MORIZ KAPOSI TO KNOWLEDGE OF CANCER AND PRECANCEROUS CON-
DiTIONS: SARCOMA AND XERODERMA PIGMENTOSUM 
Anne J. Krush 
The Moore Clinic 
The Johns Hopkins Hospital 
600 North Wolfe Street 
Baltimore, Maryland 21205 
Moriz (Moritz, Moric, Moricz) Kaposi, whose original surname was Kohn, 
was born in Kaposvar, Hungary on October 23, 1837. Though his parents 
were poor, he completed his early education at Pressburg, Bratislava, and in 
1861 received an M.D. degree at the University of Vienna. From 1866 to 
1869 he was an assistant to Dr. Ferdinand Hebra, founder and chairman of 
the Department of Dermatology at the University of Vienna. He proceeded 
from "Privatdozent" to associate professor, and later assumed Hebra's chair 
until his own death on March 6, 1902. Kaposi was intimately involved in 
almost every clinical dermatologic advance of his time. He published widely; 
students and patients came from many countries to his clinic in Vienna. His 
trainees later occupied chairs of Dermatology at many other European uni-
versities. The first descriptions of several dermatologic conditions are attributed 
to Kaposi, two of which are pigmented sarcoma ofthe skin (Kaposi's sarcoma) 
in 1872 and xeroderma pigmentosum (XDP) in 1882. His descriptive and 
clinical studies of patients with XDP antedated the discovery of the recessive 
inheritance pattern and the fact that ultraviolet light sets up the mechanism 
for malignant melanoma of the skin. He did, indeed, recognize the seriousness 
of the condition and its precancerous nature. 
t t t 
INTRODUCTION 
Moriz (Moritz, Moric, Moricz) Kaposi, whose original sur-
name was Kohn, was born in Kaposvar, Hungary on October 
23, 1837, the son of poor parents. His early education was 
obtained in Pressburg, Bratislava, and in 1861 he received the 
M.D. degree at the University of Vienna. It was there that 
Kaposi's interest in dermatology began as he worked as an 
assistant to Dr. Ferdinand Hebra who had founded and chaired 
the Department of Dermatology at that University. Kaposi soon 
became Prlvatdozent at the Allgemeines Krankenhaus after 
completing a dissertation on syphilis of the mucous membranes 
(Editorial, JAMA, 1964). 
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A short time later Kaposi married Dr. Hebra' s daughter. 
Still later, he became associate professor of Dermatology; and 
after the death of Dr. Hebra in 1881, he became chairman of 
Dermatology at the University of Vienna, a post he retained 
until his own death on March 6, 1902. 
Not only did Kaposi show excellence in his descriptions 
and knowledge of many dermatologic conditions, but he was 
knowledgeable in the descriptions of their histology and pa-
thology (Braun, 1982). He published many dermatologic pa-
pers, and his lectures attracted students, patients, and physicians 
from many other countries to his clinic. Kaposi was an excellent 
speaker and was invited to speak at many international der-
matologic meetings. Many of his students later became chair-
men of Dermatology departments in a number of European 
countries. 
Two of a number of dermatologic conditions first described 
by Kaposi are: idiopathic multiple pigmented sarcoma (Ka-
posi's sarcoma) in 1872, and xeroderma pigmentosum in 1882. 
KAPOSI'S SARCOMA 
In 1872, after having seen andfJlttempted to treat several 
patients with an unusual type of sarcoma, Kaposi's description 
entitled "Idiopathic Multiple Pigmented Sarcoma of the Skin" 
(Kaposi, 1872) was published in the Archives of Dermatology 
and Syphilology. It was also published in his book, (Kaposi, 
1880). 
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In about 1892, after further study, Kaposi suggested an-
other name for this disease, idiopathic multiple hemorrhagic 
sarcoma, which he felt best described it. He described 16 cases 
of this pigmented sarcoma in men and one boy. 
The lesions began on the soles and volar surfaces of the 
feet. Then the same surfaces of the hands became affected. He 
described the lesions as "reddish brown, later bluish red, round, 
moderately firm nodules from the size of a pea to that of a 
bean, which are in part separate and irregularly situated, in 
part arranged in groups and diffuse infiltrations varying from 
the size of a Kreuzer (a quarter) to that of the palm of the hand. 
The lesions then appear on the ankles and forearms, and in 
two to three years progress to the face and trunk of the body. 
"Later, the lesions ulcerate and become gangrenous and 
necrotic. " The prognosis was poor because no treatment was 
available. If the lesions were surgically removed, others always 
appeared. The most difficult symptom was the feeling of tight-
ness and pain in hands and feet for which such palliative pre-
scriptions as emollient ointments, cold compresses, and 
paregoric were given (Braun, 1982). In addition to the pain! 
the patients suffered from a high fever, bloody diarrhea, hem-
optysis, and general debilitation before death occurred. The 
patient died within two to three years. 
At autopsy, large numbers of lesions were also found in 
the esophagus, trachea, stomach, heart, liver, and intestinal 
tract with especially necrotic lesions in the descending colon 
(Editorial, JAMA, 1964). (Some of the lesions were described 
as the size of a silver groschen or a thaler.) 
Kaposi removed a number of the sarcomatous lesions to 
study them microscopically. He described them as follows: "A 
round-cell sarcoma is seen, except that in a few places the 
characteristic spindle-cell sarcoma is seen. A peculiarity of this 
type is the presence of capillary hemorrhages, which explain 
the later bluish-black pigmentation of the originally bluish-
red nodules, as well as the excessive hardness of the diffuse 
infiltrations around the groups of nodules caused by deposits 
of fibrin (Editorial, JAMA, 1964). 
In recent years the following interesting findings concern-
ing Kaposi's sarcoma are: 1) The ratio of male to female oc-
currence of the disease is 10: 1; 2) there are racial, geographic 
and ethnic factors, with increased occurrences among Northern 
Italians, Ashkenazi Jews, and the Bantus of South Africa; and 
3) there appear to be a number of familial occurrences so that 
an autosomal dominant gene is postulated (Lynch, 1972). 
Treatment in 1986 for Kaposi's sarcoma 
One wonders what Dr. Kaposi would think one hUndred 
years after his first description of what is now called "classical 
Kaposi's sarcoma" (CKS) as distinguished from "epidemic 
Kaposi's sarcoma" (EKS), a frequent complication in patients 
with the Auto Immune Deficiency Syndrome (AIDS). Even 
before the appearance of AIDS, it was found that patients with 
kidney transplants who were chemically immunologically sup-
pressed had not only impairment of the immune reactivity of 
the body's lymphocytes, but also many times developed Ka-
posi's sarcoma (Friedman-Kien and Laubenstein, 1984). This 
condition then regressed when the suppressive drugs were dis-
continued. 
From learning that the body's immune mechanisms are 
suppressed in patients with AIDS and that EKS was one of the 
opportunistic conditions complicating the disease, new thera-
pies for Kaposi's sarcoma became urgent. They now consist 
of radiation therapy for early lesions, chemotherapy, and biol-
ogic response modifiers, such as interferon. 
XERODERMA PIGMENTOSUM or XERODERMA, 
PARCHMENT SKIN 
Kaposi was the first dermatologist to report xerodelma pig-
mentosum (XDP) or xeroderma, parchment skin (Shelley and 
Crissey, 1953). In one of two young patients (age 18), ll.e noted 
abnormality of pigmentation while in the second (age 10) there 
was none. 
The first young lady, from one of the northern German 
states, had developed XDP in early childhood. Dr. Kaposi first 
examined her in 1863 with the following description: "The 
skin of the face, ears, throat, neck, shoulders, arms and of the 
breast to the level of the third rib . . . had a checkered ap-
pearance; it appeared to be abundantly dotted over with pig-
mented spots, the size of a pin-head or bean, and yellowish-
brown in color; it was also tightly stretched, as if contracted, 
was pinched up into a fold with difficulty, and felt very thin. 
Its surface was smooth in some places, while in others, fine 
epidermic lamellae peeled off; or there were quite flat, linear 
furrows marked out on the epidermis, so that the surface ap-
peared as dry as parchment, and wrinkled, while the skin, 
itself, was tightly stretched. In places, it was of a white color 
and was without pigment, while there also existed ... yel-
lowish or dark-brown pigmented spots resembling freckles. . . 
Beyond a sensation of tightness, the patient had no pain nor 
itching. The skin of the whole trunk and of the extremities was 
quite normal, smooth, pliant, fine. The general state of health 
was normal" (Shelley and Crissey, 1953). The skin on this 
patient's face had contracted so that her eyelids were drawn 
downward and she could not close her eyes, causing ulceration 
of the cornea. Her nose was compressed and her ears were 
indented in places, all due to the thinning and contraction of 
the skin. The patient died at age 27 from "cancer of the per-
itoneum" that presumably was not related to XPD, though 
changes in the patient's immune system may have been a factor. 
Since Kaposi's time it has been learned, first, that exposure 
to sunlight (ultraviolet light) causes skin alteration in XDP, 
melanin deposits (freckles) and, in many cases, malignant mel-
anoma of the skin. Also, it has been learned that XDP is an 
autosomal recessive disease. More recently, it has been learned 
that whereas in persons with normal skin, ultraviolet light causes 
a chain break in the DNA that can be "repaired" (Lynch, 
1972), in persons with XPD such a "repair" mechanism is 
lacking due to an enzyme deficiency (endonuclease). When 
exposed to sunlight or ultraviolet light, the skin shows path-
ologic changes that include disturbances of pigmentation and 
maturation of epidermal cells (Lynch, 1972). Even more re-
cently it has been found that the XPD gene is located on 
chromosome 1 (McKusick, 1986). 
Effective treatment for XPD now consists of using chemical 
sun screens. At an XPD Clinic at the National Institute of 
Health, it has been found that accutane, a drug used for treating 
acne, also slows tumor growth in XPD. 
Thus, Moriz Kaposi provided the initial observations of 
two diseases, one malignant and one premalignant, that later 
were found to be hereditary. 
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